NPPA - natriuretic peptide A Gene
Also Known as ANF; ANP; CDD; CDP; PND; ATFB6; ATRST2; CDD-ANF
Species: Homo sapiens
About NPPA
This gene has 2 transcripts (splice variants), 137 orthologues, 1 paralogue and is associated with 4 phenotypes. Restricted expression toward heart (RPKM 12159.5).
Summary
The protein encoded by this gene belongs to the natriuretic peptide family. Natriuretic peptides are implicated in the control of extracellular fluid volume and electrolyte homeostasis. This protein is synthesized as a large precursor (containing a signal peptide), which is processed to release a peptide from the N-terminus with similarity to vasoactive peptide, cardiodilatin, and another peptide from the C-terminus with natriuretic-diuretic activity. Mutations in this gene have been associated with atrial fibrillation familial type 6. This gene is located adjacent to another member of the natriuretic family of peptides on chromosome 1. [provided by RefSeq, Oct 2015]
NPPA Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_006172.4 | NP_006163.1 | natriuretic peptides A preproprotein |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables hormone receptor binding |
IPI
IPI: Inferred from physical interaction
|
1660465 | GOA |
| enables neuropeptide hormone activity |
IMP
IMP: Inferred from mutant phenotype
|
19646991 | GOA |
| enables neuropeptide receptor binding |
IMP
IMP: Inferred from mutant phenotype
|
19646991 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
25416956 | GOA |
| enables signaling receptor binding |
IDA
IDA: Inferred from direct assay
|
1672777 | GOA |
| enables signaling receptor binding |
IPI
IPI: Inferred from physical interaction
|
16870210 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| part of protein-containing complex |
IDA
IDA: Inferred from direct assay
|
16870210 | GOA |
NPPA Protein Structure
ANP: Atrial natriuretic peptide (122 - 146)
- 0
- 100
- 151 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
natriuretic peptides A |
|
NPPA Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
NPPA | P01160 | HSF2BP | Homo sapiens | O75031 | 32296183 | |
|
Intra
|
NPPA | P01160 | HSF2BP | Homo sapiens | O75031 | 32296183 | |
|
Intra
|
NPPA | P01160 | UBQLN1 | Homo sapiens | Q9UMX0 | 25416956 | |
|
Intra
|
NPPA | P01160 | UBQLN1 | Homo sapiens | Q9UMX0 | 25416956 | |
|
Intra
|
NPPA | P01160 | MAGEA12 | Homo sapiens | P43365 | 32296183 | |
|
Intra
|
NPPA | P01160 | MAGEA12 | Homo sapiens | P43365 | 32296183 | |
|
Intra
|
NPPA | P01160 | MAGEA12 | Homo sapiens | P43365 | 25416956 | |
|
Intra
|
NPPA | P01160 | MAGEA12 | Homo sapiens | P43365 | 32296183 | |
|
Intra
|
NPPA | P01160 | UBQLN2 | Homo sapiens | Q9UHD9 | 32296183 | |
|
Intra
|
NPPA | P01160 | UBQLN2 | Homo sapiens | Q9UHD9 | 32296183 | |
|
Intra
|
NPPA | P01160 | UBQLN2 | Homo sapiens | Q9UHD9 | 32296183 |
Recombinant NPPA Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P700563 | Natriuretic peptides A/NPPA Protein, Human (P. pastoris, His) | P01160 (P78-L115) | ≥ 90%, as determined by reducing SDS-PAGE. |
NPPA Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P810744 | Natriuretic peptides A Antibody (YA9987) | WB, ICC/IF | Human |
| HY-P81636 | Natriuretic Peptides A Antibody (YA1381) | WB, IP | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Atrial Standstill 2 |
|
|
| Atrial Fibrillation, Familial, 6 |
|
|
| Atrial Standstill |
|
|
| Familial Atrial Fibrillation |
|
|
| Atrial Fibrillation |
|
|
| Congestive Heart Failure |
|
|
| Mitral Valve Disease |
|
|
| Acute Kidney Failure |
|
|
| Heart Disease |
|
|
| Renovascular Hypertension |
|
|
| Hepatorenal Syndrome |
|
|
| Pulmonary Hypertension |
|
|
| Inappropriate Adh Syndrome |
|
|
| Mitral Valve Stenosis |
|
|
| Heart Valve Disease |
|
|
| Syncope |
|
|
| Acute Kidney Tubular Necrosis |
|
|
| Liver Cirrhosis |
|
|
| Idiopathic Edema |
|
|
| Acute Myocardial Infarction |
|
|
| Hypertension, Essential |
|
|
| Gastroschisis |
|
|
| Malignant Hypertension |
|
|
| Conn'S Syndrome |
|
|
| Myxedema |
|
|
| Mitral Valve Insufficiency |
|
|
| Hypoaldosteronism |
|
|
| Cardiogenic Shock |
|
|
| Kidney Disease |
|
|
| Hypertensive Heart Disease |
|
|
| Aortic Valve Disease 2 |
|
|
| Pericardial Effusion |
|
|
| Multiple Personality Disorder |
|
|
| Hypoplastic Left Heart Syndrome |
|
|
| Ventricular Septal Defect |
|
|
| Myocardial Infarction |
|
|
| Dissociative Disorder |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Dilated Cardiomyopathy |
|
|
| Intracranial Arteriosclerosis |
|
|
| Pulmonary Edema |
|
|
| Acute Necrotizing Pancreatitis |
|
|
| Pre-Eclampsia |
|
|
| Tetralogy Of Fallot |
|
|
| Hepatic Encephalopathy |
|
|
| Sick Sinus Syndrome |
|
|
| Pure Autonomic Failure |
|
|
| Pheochromocytoma |
|
|
| Type 1 Diabetes Mellitus |
|
|
| Nephrotic Syndrome |
|
|
| Depersonalization Disorder |
|
|
| Anterolateral Myocardial Infarction |
|
|
| Cardiovascular System Disease |
|
|
| Myocarditis |
|
|
| Vasculogenic Impotence |
|
|
| Nephrogenic Diabetes Insipidus |
|
|
| Polyomavirus-Associated Nephropathy |
|
|
| Chronic Kidney Disease |
|
|
| Holt-Oram Syndrome |
|
|
| Intrinsic Cardiomyopathy |
|
|
| Heart Septal Defect |
|
|
| Heart Conduction Disease |
|
|
| Scoliosis |
|
|
| Diabetes Mellitus |
|
|
| Atrial Heart Septal Defect |
|
|
| Cerebral Palsy |
|
|
| Stroke, Ischemic |
|
|
| Noonan Syndrome 1 |
|
|
| Hypertrophic Cardiomyopathy |
|
|
| Brugada Syndrome |
|
|
| Patent Foramen Ovale |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Bos taurus | NPPA | VGNC | VGNC:32210 |
| Rattus norvegicus | NPPA | RGD | RGD:3193 |
| Mus musculus | NPPA | MGD | MGI:97367 |
| Macaca mulatta | NPPA | VGNC | VGNC:75386 |
| Canis familiaris | NPPA | VGNC | VGNC:43925 |
| Others | NPPA | NCBI |